Press Releases

CellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and Companion Diagnostic Programs Across Drug Development

CellCarta and Imagene AI today announced an expanded collaboration to provide a coordinated path for biopharma companies to validate, deploy, and scale AI-powered biomarker and companion diagnostic programs.

Advarra Launches Site Identification Technology with Insights Directly from Sites

Advarra today announced the launch of its new Site ID technology.

PumasAI Brings AI, Scientific Machine Learning and Advanced Pharmacometric Research to ACoP 2026

Pre-conference workshop on the future of AI in pharmacometrics and four scientific poster presentations highlight PumasAI’s presence at the American Conference on Pharmacometrics (ACoP)

Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth

Three new commercial appointments for Symbiosis to drive international growth

Ceryx Medical appoints Professor Zaheer Yousef OBE as Chief Medical Officer

Ceryx Medical has appointed Professor Zaheer Yousef OBE as Chief Medical Officer. Professor Yousef is a consultant cardiologist at the University Hospital of Wales and was principal investigator on RSA-Pace, Ceryx's multi-centre study of its respiratory sinus arrhythmia pacing technology. He joins as the company moves towards a clinical study designed to demonstrate the full clinical benefit of its implantable device in people living with heart failure.

Biopharma PEG Expands Functionalized PEG Linker Portfolio for Bioconjugation Research

Biopharma PEG expands its portfolio of functionalized PEG linkers for bioconjugation and pharmaceutical research, including azide, alkyne, DBCO, and BCN PEG derivatives, alongside monodispersed, polydispersed, and custom PEG solutions.

Huateng Pharma to Showcase High-Purity PEG Products and CDMO Capabilities at CPHI Milan 2026

Hunan Huateng Pharmaceutical Co., Ltd. will exhibit at CPHI Milan 2026, Booth 3H94, showcasing high-purity PEG products, pharmaceutical intermediates, APIs, and CDMO capabilities. The company supports pharmaceutical and biopharmaceutical projects from research and process development through manufacturing.

Quotient Sciences and Acesion Pharma Announce Collaboration on AI-Enhanced Formulation Development to Advance Atrial Fibrillation Pipeline

The University of Turin Adopts Openwater’s Open-Motion Device to Study Muscle Blood Flow and Vascular Responses

Researchers in the University’s Integrative Physiology Lab will evaluate Openwater’s wearable platform for studying muscle blood-flow dynamics and vascular responses to nervous system activity, with potential future applications in noninvasive neural communication

Systech Launches New All-in-One Pharma Packaging and Serialization Stations

Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth

Sygnature Discovery establishes DEL screening collaboration with X-Chem

Johnson County ClinTrials (JCCT) Rebrands as Sequoia Clinical Research

New identity unites three site organizations under one banner as company expands beyond its vaccine-trial roots into multi-therapeutic clinical research site network

Astoriom Acquires Additional UK Storage Business to Expand Capacity and Service Offerings

• Acquisition of Sampled’s UK facility strengthens Astoriom’s position as a trusted provider of secure, compliant and quality-led sample stability and biorepository storage solutions • Offers broader coverage, additional technical expertise and increased operational resilience to help safeguard critical samples

New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day

Veeva Systems today announced Veeva Study Builder Agent, a new AI solution that configures Veeva EDC and Veeva DQS (Data Quality System) directly from a study protocol.

New Publication Associates SherpaPak® Cardiac Transport System with Lower Costs Across Heart Transplant Care

Published in the special Focus Issue on Innovations in Heart Transplantation in the Journal of Cardiac Failure, the GUARDIAN-Heart analysis across 18 U.S. transplant centers identifies $14,982 in net per-patient cost savings across multiple measured categories spanning post-transplant support, hospital care, organ preservation, and readmissions.

BOC Sciences Announces October 2026 Webinars on Vaccine Development and DNA-Encoded Chemistry

Complex-molecule specialist Shilpa CDMO launches at CPHI Milan

Upperton granted MHRA licence for Annex 1 aligned sterile manufacturing facility

Upperton, a UK-based contract development and manufacturing organisation (CDMO), today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has approved a variation to its existing Manufacturing and Importation Authorisation for Investigational Medicinal Products (MIA(IMP)) licence, extending its scope to include the company’s new Annex 1-aligned sterile manufacturing facility at Trent Gateway, Nottingham.